Firstly, CCK8 and EdU assays indicated that silencing CAPON showed more significant influences on glioma cell proliferation than the overexpression of CAPON-S (p < 0.01 vs. p < 0.05), verifying the contribution of CAPON-L to cell proliferation. The gene discussed is NOS1AP; the disease is central nervous system cancer.